化学
DNA损伤
DNA
突变
细胞生物学
A549电池
自旋俘获
突变
分子生物学
激进的
DNA修复
细胞
硝基
髓过氧化物酶
次氯酸
基因组DNA
体外
嘧啶二聚体
生物化学
染色体易位
染色质
氧化应激
8-羟基-2'-脱氧鸟苷
基因
细胞培养
基因组不稳定性
作者
Cristofer Martín Lopez,Darío C. Ramírez,Sandra Gomez-Mejiba
摘要
Pulmonary neutrophilic inflammation (PNI) is the recruitment and activation of neutrophils in the microvasculature with the release of myeloperoxidase (MPO) in the airways. Bystander epithelial cells can take up MPO, where it can generate HOCl. HOCl can react with DNA, generating DNA radicals, which then decay to produce several mutagenic end‐oxidation products, such as 8‐oxo‐7,8‐dihydro‐2’‐deoxyguanosine (8‐oxo‐dGuo). Herein, we aimed to test whether HOCl‐induced DNA radicals precede DNA oxidation and mutagenesis in A549 human lung epithelial cells as an in vitro model that resembles PNI. Interestingly, by trapping HOCl‐induced DNA radicals, the nitrone spin trap 5,5‐dimethyl‐1‐pyrroline N‐oxide (DMPO) blocks the formation of 8‐oxo‐dGuo and possibly other end‐oxidation products, forming DNA‐DMPO nitrone adducts. By preventing DNA oxidation, DMPO reduces the mutation of the hypoxanthine phosphoribosyl transferase ( hrpt ) gene, one of the genes most sensitive to oxidative damage. The transcription factor p53 is known as the master regulator of the cell response to genomic damage. By trapping DNA radicals, DMPO also blocks the translocation of p53 to the cell nucleus, suggesting that by trapping DNA radicals with DMPO, end‐oxidation products are prevented, and the cell response to genomic damage is blunted. Trapping DNA radicals to reduce the accumulation of HOCl‐induced mutagenic end‐oxidation products will provide new therapeutic avenues to reduce genotoxic damage during PNI.
科研通智能强力驱动
Strongly Powered by AbleSci AI